- Contatos com a mídia
- Precisa entrar em contato conosco? Dirija-se à nossa equipe de mídia com suas dúvidas.
We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
Comunicados à imprensa
Leadership Announcements and New Arcera Structure
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
Read more
Acino Publishes Second Annual Sustainability Report
Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...
Read more
Acino signs an exclusive agreement with LG Chem for Novel Treatments for...
Acino will market, commercialize, and distribute Hyruan One® in Brazil, and Zemiglo® and Zemimet® SR (Zemiduo® SR in Mexico) in...
Read more
Acino signs an exclusive license agreement with Supernus in Latin America
Acino will collaborate with Supernus to develop and commercialize products for the treatment of diseases of the central nervous system...
Read more
Acino announces new regional leadership and hub to deliver on expanded presence...
Joel Barlan has been appointed as Head of the LATAM region. Mexico City will now serve as a regional hub...
Read more
Acino signs an exclusive license agreement with SERB Pharmaceuticals in Latin America
We are collaborating to bring an important orphan drug for cancer patients to Latin America.
Read more
Acino Completes Acquisition of M8 Pharmaceuticals Significantly Expanding Presence and Capabilities in...
Acino will enhance its presence in Latin America and strengthen its business through new partnerships, innovative and proven portfolio and...
Read more
Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of...
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets.
Read more
